Washington, District of Columbia, United States The venture was found in North America in United States. The main office of represented VC is situated in the Washington.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - United Kingdom. Among the most popular portfolio startups of the fund, we may highlight Cytox, MediQuest Therapeutics. We can highlight the next thriving fund investment areas, such as Biotechnology, Health Care.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Masa Life Science Fund, startups are often financed by Novo Holdings, National Institutes of Health, Kentucky Science and Technology Corporation (KSTC). The meaningful sponsors for the fund in investment in the same round are Integra Ventures, Qi3 Ventures, Pegasus Capital. In the next rounds fund is usually obtained by Wren Capital, Kentucky Science and Technology Corporation (KSTC), Walking Ventures.
Deals in the range of 10 - 50 millions dollars are the general things for fund. Comparing to the other companies, this Masa Life Science Fund performs on 4 percentage points less the average number of lead investments. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2009.
The current fund was established by Sinclair Dunlop. Besides them, we counted 2 critical employees of this fund in our database.
Related Funds
Funds with similar focus
| Fund Name | Location |
| 9-1-1 Association of Central Oklahoma Governments | - |
| ADATA Technology | Taipei, Taiwan |
| Attractor Investment Management | Seattle, United States, Washington |
| Business Angels Technostarters | Haaksbergen, Overijssel, The Netherlands |
| Canaan Valley Capital | Connecticut, Old Greenwich, United States |
| Circus Future | Mölndal, Sweden, Vastra Gotaland |
| Dyna Investment | Alberta, Calgary, Canada |
| FleetBoston Financial Group | Boston, Massachusetts, United States |
| Hanaco Venture Capital | Israel, Tel Aviv, Tel Aviv District |
| Hanyang Capital | China, Shanghai |
| Innozate | - |
| Logan Capital AG | Sankt Gallen, Sankt Gallen, Switzerland |
| Marathon Venture Capital | Athens, Attiki, Greece |
| New Venture Partners | Berkeley Heights, New Jersey, United States |
| SAC | China, Guangdong, Shenzhen |
| Seed X Liechtenstein | Liechtenstein, Schaan, Schaan |
| The Asahi Shimbun Company | Chiyoda, Japan |
| Tongding Interconnection | China, Jiangsu, Suzhou |
| UBC Seed Fund | - |
| Xin Yuanjing Youcheng | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Apellis Pharmaceuticals | $3M | 20 Jun 2011 | Massachusetts, United States | ||
Cytox | $822K | 24 Jun 2009 | England | ||
MediQuest Therapeutics | $23M | 16 Jun 2009 | Washington, United States | ||
MediQuest Therapeutics | $16M | 15 Jun 2006 | Washington, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Apellis Pharmaceuticals | $3M | 20 Jun 2011 | Massachusetts, United States | ||
Cytox | $822K | 24 Jun 2009 | England | ||
MediQuest Therapeutics | $23M | 16 Jun 2009 | Washington, United States | ||
MediQuest Therapeutics | $16M | 15 Jun 2006 | Washington, United States |
